Community Shares | July 29th 2024
This week’s articles: A new research article has investigated the levels of certain trace elements—zinc (Zn), aluminum (Al), and selenium (Se)—in the blood of children with ASD and compared them to healthy controls; A mini-review article for parents considering medication for children with ADHD or ASD emphasizes that while these treatments can be beneficial, drugs should be used cautiously; A review article has explored various immune-modulating treatments for neuroinflammation in individuals with ASD; An umbrella review has synthesized data from previous systematic reviews and meta-analyses to evaluate the link between vitamin D and ASD.
Community Shares | July 8th 2024
A new review has investigated the potential use of immunomodulating agents to treat neuroinflammation in patients with autism, who often do not respond to standard treatments. Neuroinflammation, influenced by genetic, epigenetic, and environmental factors, is considered a significant contributor to ASD. This work highlights that some existing anti-inflammatory treatments have shown promise, including corticosteroids, intravenous […]
